Autobahn Therapeutics Funding: $176M Raised, Series B (2020)
Autobahn Therapeutics is based in San Diego, CA. It has raised $176M in total funding. Latest round: Series B.
Autobahn Therapeutics funding overview
Autobahn Therapeutics is based in San Diego, CA. Autobahn Therapeutics has raised $176M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in June 2020. The round record for Autobahn Therapeutics runs through 2020; nothing later has been disclosed. Investors on record include ARCH Venture Partners, Cowen Healthcare Investments, BVF Partners L.P., Biogen, Bristol Myers Squibb, Pfizer Ventures and 4 others. 10 distinct backers are named across the disclosed rounds.
Frequently asked about Autobahn Therapeutics funding
How much has Autobahn Therapeutics raised?
Autobahn Therapeutics has raised $176M in total disclosed funding across the rounds on record.
Who has invested in Autobahn Therapeutics?
ARCH Venture Partners, Cowen Healthcare Investments, BVF Partners L.P., Biogen, Bristol Myers Squibb, Pfizer Ventures are named among the investors backing Autobahn Therapeutics.
What was the latest Autobahn Therapeutics funding round?
The most recent disclosed round is a Series B, announced in June 2020.
Where is Autobahn Therapeutics based?
Autobahn Therapeutics is based in San Diego, CA.
When did Autobahn Therapeutics last raise?
The last disclosed Autobahn Therapeutics round closed in June 2020 at Series B.
Every Autobahn Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in San Diego at a similar stage.
